董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Manuel Kadre | 男 | Director | 55 | 未披露 | 未持股 | 2021-06-23 |
| Kedrick D. Adkins Jr. | 男 | Director | 68 | 31.59万美元 | 未持股 | 2021-06-23 |
| Naomi Allen | 女 | Director | 47 | 31.59万美元 | 未持股 | 2021-06-23 |
| Jeffrey Folick | 男 | Director | 73 | 未披露 | 未持股 | 2021-06-23 |
| Linda Gooden | 女 | Director | 68 | 未披露 | 未持股 | 2021-06-23 |
| Jeffery R. Immelt | 男 | Director | 65 | 30.84万美元 | 未持股 | 2021-06-23 |
| Mohamad Makhzoumi | 男 | Director | 41 | 未披露 | 未持股 | 2021-06-23 |
| Adair Newhall | 男 | Director | 42 | 未披露 | 未持股 | 2021-06-23 |
| Robert J. Sheehy | 男 | Chairman of the Board | 63 | 未披露 | 未持股 | 2021-06-23 |
| Manuel Kadre | 男 | Director | 55 | 41.04万美元 | 未持股 | 2021-06-23 |
| Stephen Kraus | 男 | Director | 44 | 未披露 | 未持股 | 2021-06-23 |
| G. Mike Mikan | 男 | Chief Executive Officer, President and Director | 50 | 548.88万美元 | 未持股 | 2021-06-23 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sam K. Srivastava | 男 | Chief Executive Officer, NeueHealth | 53 | 126.16万美元 | 未持股 | 2021-06-23 |
| Catherine R. Smith | 女 | Chief Financial and Administrative Officer | 57 | 158.23万美元 | 未持股 | 2021-06-23 |
| Tomas Valdivia | -- | Chief Health and Equity Officer | 59 | 未披露 | 未持股 | 2021-06-23 |
| Keith Nelsen | 男 | General Counsel and Corporate Secretary | 57 | 165.98万美元 | 未持股 | 2021-06-23 |
| Simeon Schindelman | 男 | Chief Executive Officer, Bright HealthCare | 58 | 126.54万美元 | 未持股 | 2021-06-23 |
| G. Mike Mikan | 男 | Chief Executive Officer, President and Director | 50 | 548.88万美元 | 未持股 | 2021-06-23 |
董事简历
中英对照 | 中文 | 英文- Manuel Kadre
-
Manuel Kadre，他是MBB Auto Group（高档豪华零售汽车集团，在东北部有许多经销店）的董事长兼首席执行官（2012年以来）。Kadre先生还担任共和废品处理公司的董事会主席，这是一家美国回收和非危险固体废物处理的行业领导者。在担任现职之前，他曾于2009年7月至2014年担任Gold Coast Caribbean Importers，LLC的首席执行官。Kadre从1995年到2009年7月担任CC1Companies，Inc.（加勒比地区市场饮料产品分销商）总裁、副总裁、总法律顾问和秘书。Kadre先生还担任迈阿密大学董事会成员。
Manuel Kadre has served as a director since November 2020. Mr. Kadre is Chairman and Chief Executive Officer of MBB Auto Group, a premium luxury retail automotive group with a number of dealerships in the Northeast, a position he has held since 2012. Prior to his current role, Mr. Kadre was the Chief Executive Officer of Gold Coast Caribbean Importers, LLC from July 2009 until 2014. From 1995 until July 2009 Mr. Kadre served in various roles, including President, Vice President, General Counsel and Secretary, for CC1 Companies, Inc., a distributor of beverage products in markets throughout the Caribbean. Mr. Kadre is currently a member of the board of directors of Florida Free Trade Area of the Americas, Miami International Airport Blue Ribbon Aviation Panel and Florida Self-Insurers Guaranty Association, and is Chairman of the United Way Alexis de Tocqueville Society. Mr. Kadre serves as Chairman of the Board of Republic Services, Inc. and serves on the boards of directors of The Home Depot, Inc., Mednax Services, Inc. and the Board of Trustees of the University of Miami. - Manuel Kadre，他是MBB Auto Group（高档豪华零售汽车集团，在东北部有许多经销店）的董事长兼首席执行官（2012年以来）。Kadre先生还担任共和废品处理公司的董事会主席，这是一家美国回收和非危险固体废物处理的行业领导者。在担任现职之前，他曾于2009年7月至2014年担任Gold Coast Caribbean Importers，LLC的首席执行官。Kadre从1995年到2009年7月担任CC1Companies，Inc.（加勒比地区市场饮料产品分销商）总裁、副总裁、总法律顾问和秘书。Kadre先生还担任迈阿密大学董事会成员。
- Manuel Kadre has served as a director since November 2020. Mr. Kadre is Chairman and Chief Executive Officer of MBB Auto Group, a premium luxury retail automotive group with a number of dealerships in the Northeast, a position he has held since 2012. Prior to his current role, Mr. Kadre was the Chief Executive Officer of Gold Coast Caribbean Importers, LLC from July 2009 until 2014. From 1995 until July 2009 Mr. Kadre served in various roles, including President, Vice President, General Counsel and Secretary, for CC1 Companies, Inc., a distributor of beverage products in markets throughout the Caribbean. Mr. Kadre is currently a member of the board of directors of Florida Free Trade Area of the Americas, Miami International Airport Blue Ribbon Aviation Panel and Florida Self-Insurers Guaranty Association, and is Chairman of the United Way Alexis de Tocqueville Society. Mr. Kadre serves as Chairman of the Board of Republic Services, Inc. and serves on the boards of directors of The Home Depot, Inc., Mednax Services, Inc. and the Board of Trustees of the University of Miami.
- Kedrick D. Adkins Jr.
-
KedrickD.AdkinsJr.自2020年2月起担任董事。Adkins先生从2014年到2017年底退休，一直担任Mayo Clinic的首席财务官。从2007年到2014年，他还担任Trinity Health Care的综合服务总裁。在Trinity Health Care任职之前，Adkins先生在全球管理咨询公司埃森哲（Accenture）任职30年。Adkins先生是注册会计师。Adkins先生目前担任Proassurance Corporation的董事和审计委员会成员。Adkins先生目前是Welsh，Carson，Anderson&Stowe（一家专注于医疗保健和技术的投资公司）的顾问委员会，以及Christus Health，密歇根大学医院系统和Medical Memory（一家医疗技术初创公司）的董事会成员。
Kedrick D. Adkins Jr. has served as a director since February 2020. Mr. Adkins served as the Chief Financial Officer for the Mayo Clinic from 2014 through his retirement at the end of 2017. He also served as the President of Integrated Services of Trinity Health Care from 2007 to 2014. Prior to his service at Trinity Health Care, Mr. Adkins had a 30-year tenure at Accenture, a global management consulting firm. Mr. Adkins is a certified public accountant. Mr. Adkins currently serves as a director and member of the audit committee for ProAssurance Corporation. Mr. Adkins currently serves on the Advisory Board of Welsh, Carson, Anderson & Stowe, an investment firm specializing in healthcare and technology, and the board of directors for CHRISTUS Health, the University of Michigan Hospital System, and Medical Memory, a medical technology startup. - KedrickD.AdkinsJr.自2020年2月起担任董事。Adkins先生从2014年到2017年底退休，一直担任Mayo Clinic的首席财务官。从2007年到2014年，他还担任Trinity Health Care的综合服务总裁。在Trinity Health Care任职之前，Adkins先生在全球管理咨询公司埃森哲（Accenture）任职30年。Adkins先生是注册会计师。Adkins先生目前担任Proassurance Corporation的董事和审计委员会成员。Adkins先生目前是Welsh，Carson，Anderson&Stowe（一家专注于医疗保健和技术的投资公司）的顾问委员会，以及Christus Health，密歇根大学医院系统和Medical Memory（一家医疗技术初创公司）的董事会成员。
- Kedrick D. Adkins Jr. has served as a director since February 2020. Mr. Adkins served as the Chief Financial Officer for the Mayo Clinic from 2014 through his retirement at the end of 2017. He also served as the President of Integrated Services of Trinity Health Care from 2007 to 2014. Prior to his service at Trinity Health Care, Mr. Adkins had a 30-year tenure at Accenture, a global management consulting firm. Mr. Adkins is a certified public accountant. Mr. Adkins currently serves as a director and member of the audit committee for ProAssurance Corporation. Mr. Adkins currently serves on the Advisory Board of Welsh, Carson, Anderson & Stowe, an investment firm specializing in healthcare and technology, and the board of directors for CHRISTUS Health, the University of Michigan Hospital System, and Medical Memory, a medical technology startup.
- Naomi Allen
-
Naomi Allen自2020年2月起担任董事。自2019年10月以来，艾伦女士一直担任Brightline，Inc.的首席执行官兼联合创始人。从2018年4月至2019年10月，艾伦女士担任LivongoHealth，Inc.的首席增长官，负责监督关键的战略增长计划。在加入LivongoHealth，Inc.之前，艾伦女士于2017年2月至2018年4月担任Play Bigger的类别设计师。在加入Play Bigger之前，Allen女士于2015年12月至2017年2月休假，并于2008年4月至2015年12月在CastlightHealth，Inc.担任多个执行职位。
Naomi Allen has served as a director since February 2020. Since October 2019 Ms. Allen has served as the Chief Executive Officer and Co-founder of Brightline, Inc. From April 2018 until October 2019 Ms. Allen served as the Chief Growth Officer at Livongo Health, Inc., overseeing key strategic growth initiatives. Prior to Livongo Health, Inc., Ms. Allen was a category designer at Play Bigger from February 2017 to April 2018. Prior to joining Play Bigger, Ms. Allen was on sabbatical from December 2015 until February 2017 and also held various executive positions at Castlight Health, Inc. from April 2008 until December 2015. - Naomi Allen自2020年2月起担任董事。自2019年10月以来，艾伦女士一直担任Brightline，Inc.的首席执行官兼联合创始人。从2018年4月至2019年10月，艾伦女士担任LivongoHealth，Inc.的首席增长官，负责监督关键的战略增长计划。在加入LivongoHealth，Inc.之前，艾伦女士于2017年2月至2018年4月担任Play Bigger的类别设计师。在加入Play Bigger之前，Allen女士于2015年12月至2017年2月休假，并于2008年4月至2015年12月在CastlightHealth，Inc.担任多个执行职位。
- Naomi Allen has served as a director since February 2020. Since October 2019 Ms. Allen has served as the Chief Executive Officer and Co-founder of Brightline, Inc. From April 2018 until October 2019 Ms. Allen served as the Chief Growth Officer at Livongo Health, Inc., overseeing key strategic growth initiatives. Prior to Livongo Health, Inc., Ms. Allen was a category designer at Play Bigger from February 2017 to April 2018. Prior to joining Play Bigger, Ms. Allen was on sabbatical from December 2015 until February 2017 and also held various executive positions at Castlight Health, Inc. from April 2008 until December 2015.
- Jeffrey Folick
-
Jeffrey Folick自2016年6月起担任董事，拥有超过30年的管理医疗保健领导经验。最近，从2006年1月到2010年11月退休，Folick先生担任Bravo Health，Inc.的董事长兼首席执行官，该公司于2010年被HealthSpring，Inc.收购。从2009年到2019年，Folick先生还担任Frazier医疗保健Partners的高级顾问。在加入Bravo Health，Inc.之前，Folick先生在HealthNet，Inc.和Pacificare Health Systems担任关键领导职位。自2011年从Bravo Health，Inc.退休以来，Folick先生还曾在许多其他私营公司的董事会任职。
Jeffrey Folick has served as a director since June 2016 and has over 30 years of managed healthcare leadership experience. Most recently, Mr. Folick was the Chairman and Chief Executive Officer of Bravo Health, Inc., which was acquired by Healthspring, Inc. in 2010 from January 2006 until his retirement in November 2010. From 2009 to 2019 Mr. Folick also served as a Senior Advisor to Frazier Healthcare Partners. Prior to joining Bravo Health, Inc., Mr. Folick held key leadership positions at Health Net, Inc. and PacifiCare Health Systems. Mr. Folick has also served on the boards of a number of other privately-held companies since his retirement from Bravo Health, Inc. in 2011. - Jeffrey Folick自2016年6月起担任董事，拥有超过30年的管理医疗保健领导经验。最近，从2006年1月到2010年11月退休，Folick先生担任Bravo Health，Inc.的董事长兼首席执行官，该公司于2010年被HealthSpring，Inc.收购。从2009年到2019年，Folick先生还担任Frazier医疗保健Partners的高级顾问。在加入Bravo Health，Inc.之前，Folick先生在HealthNet，Inc.和Pacificare Health Systems担任关键领导职位。自2011年从Bravo Health，Inc.退休以来，Folick先生还曾在许多其他私营公司的董事会任职。
- Jeffrey Folick has served as a director since June 2016 and has over 30 years of managed healthcare leadership experience. Most recently, Mr. Folick was the Chairman and Chief Executive Officer of Bravo Health, Inc., which was acquired by Healthspring, Inc. in 2010 from January 2006 until his retirement in November 2010. From 2009 to 2019 Mr. Folick also served as a Senior Advisor to Frazier Healthcare Partners. Prior to joining Bravo Health, Inc., Mr. Folick held key leadership positions at Health Net, Inc. and PacifiCare Health Systems. Mr. Folick has also served on the boards of a number of other privately-held companies since his retirement from Bravo Health, Inc. in 2011.
- Linda Gooden
-
Linda Gooden自2020年11月起担任董事。Gooden女士在洛克希德马丁公司担任了30多年的各种高级领导职务，最近从2007年到2013年担任信息系统与全球解决方案（IS&GS&8221；）的执行副总裁。在她担任IS&GS执行副总裁的领导下，洛克希德将其IT能力从政府客户扩展到国际和商业市场。她也曾担任Lockheed公司的副执行副总裁，负责信息和技术服务（从2006年10月到12月），以及其信息技术总裁（从1997年到2006年12月）。在担任洛克希德公司IT部门总裁期间，古登在10年的时间里将公司发展成为一家价值数十亿美元的公司。在过去的五年中，Gooden女士在通用汽车公司，家得宝公司，自动数据处理公司，WGL控股公司和Washington Gas&Light Company（WGL控股公司的子公司）的董事会任职。
Linda Gooden has served as a director since November 2020. Ms. Gooden has served over 30 years in various senior leadership roles with Lockheed Martin Corporation “Lockheed”, most recently as Executive Vice President, Information Systems & Global Solutions (“IS&GS”) from 2007 to 2013. Under her leadership as Executive Vice President of IS&GS, Lockheed expanded its IT capabilities beyond government customers to international and commercial markets. She also served as Lockheed’s Deputy Executive Vice President, Information and Technology Services from October to December 2006 and its President, Information Technology from 1997 to December 2006. In her role as President of Lockheed’s IT division, Ms. Gooden grew the business over a 10-year period to become a multibillion dollar business. In the past five years, Ms. Gooden has served on the board of directors of General Motors Company, The Home Depot, Inc., Automatic Data Processing, Inc., WGL Holdings, Inc. and Washington Gas & Light Company, a subsidiary of WGL Holdings, Inc. - Linda Gooden自2020年11月起担任董事。Gooden女士在洛克希德马丁公司担任了30多年的各种高级领导职务，最近从2007年到2013年担任信息系统与全球解决方案（IS&GS&8221；）的执行副总裁。在她担任IS&GS执行副总裁的领导下，洛克希德将其IT能力从政府客户扩展到国际和商业市场。她也曾担任Lockheed公司的副执行副总裁，负责信息和技术服务（从2006年10月到12月），以及其信息技术总裁（从1997年到2006年12月）。在担任洛克希德公司IT部门总裁期间，古登在10年的时间里将公司发展成为一家价值数十亿美元的公司。在过去的五年中，Gooden女士在通用汽车公司，家得宝公司，自动数据处理公司，WGL控股公司和Washington Gas&Light Company（WGL控股公司的子公司）的董事会任职。
- Linda Gooden has served as a director since November 2020. Ms. Gooden has served over 30 years in various senior leadership roles with Lockheed Martin Corporation “Lockheed”, most recently as Executive Vice President, Information Systems & Global Solutions (“IS&GS”) from 2007 to 2013. Under her leadership as Executive Vice President of IS&GS, Lockheed expanded its IT capabilities beyond government customers to international and commercial markets. She also served as Lockheed’s Deputy Executive Vice President, Information and Technology Services from October to December 2006 and its President, Information Technology from 1997 to December 2006. In her role as President of Lockheed’s IT division, Ms. Gooden grew the business over a 10-year period to become a multibillion dollar business. In the past five years, Ms. Gooden has served on the board of directors of General Motors Company, The Home Depot, Inc., Automatic Data Processing, Inc., WGL Holdings, Inc. and Washington Gas & Light Company, a subsidiary of WGL Holdings, Inc.
- Jeffery R. Immelt
-
Jeffery R.Immelt自2020年4月起担任董事。自2018年以来，伊梅尔特先生一直担任风险投资公司New Enterprise Associates的技术和医疗保健投资团队的风险合伙人。2001年至2017年，伊梅尔特先生担任通用电气公司的董事长兼首席执行官。伊梅尔特先生于1982年加入通用电气，并在担任首席执行官之前在公司内担任过各种职务。他目前任职于Collective Health公司、TwilioInc.（在那里他也是薪酬委员会的成员）、Desktop Metal公司（在那里他也是审计委员会的成员）、Bloom Energy Cooperation公司（在那里他也是审计委员会的成员）的董事会。
Jeffery R. Immelt has served as a director since April 2020. Since 2018 Mr. Immelt has served as a venture partner on the technology and healthcare investing teams for New Enterprise Associates, a venture capital firm. From 2001 to 2017 Mr. Immelt served as the Chairman and Chief Executive Officer of General Electric Company. Mr. Immelt joined General Electric in 1982 and held various roles within the company before assuming his position as Chief Executive Officer. Mr. Immelt currently serves on the boards of Collective Health, Inc., Twilio Inc., where he is also a member of the compensation committee, Desktop Metal, Inc., where he is also a member of the audit committee, and Bloom Energy Cooperation, where he is also a member of the audit committee. - Jeffery R.Immelt自2020年4月起担任董事。自2018年以来，伊梅尔特先生一直担任风险投资公司New Enterprise Associates的技术和医疗保健投资团队的风险合伙人。2001年至2017年，伊梅尔特先生担任通用电气公司的董事长兼首席执行官。伊梅尔特先生于1982年加入通用电气，并在担任首席执行官之前在公司内担任过各种职务。他目前任职于Collective Health公司、TwilioInc.（在那里他也是薪酬委员会的成员）、Desktop Metal公司（在那里他也是审计委员会的成员）、Bloom Energy Cooperation公司（在那里他也是审计委员会的成员）的董事会。
- Jeffery R. Immelt has served as a director since April 2020. Since 2018 Mr. Immelt has served as a venture partner on the technology and healthcare investing teams for New Enterprise Associates, a venture capital firm. From 2001 to 2017 Mr. Immelt served as the Chairman and Chief Executive Officer of General Electric Company. Mr. Immelt joined General Electric in 1982 and held various roles within the company before assuming his position as Chief Executive Officer. Mr. Immelt currently serves on the boards of Collective Health, Inc., Twilio Inc., where he is also a member of the compensation committee, Desktop Metal, Inc., where he is also a member of the audit committee, and Bloom Energy Cooperation, where he is also a member of the audit committee.
- Mohamad Makhzoumi
-
Mohamad Makhzoumi自2016年3月起担任董事。他是New Enterprise Associates公司的普通合伙人兼全球医疗保健主管，在那里他曾担任多种职务（2005年以来）。在加入New Enterprise Associates之前，Makhzoumi先生担任Summit Partners，L.P.的合伙人和瑞银集团股份公司的分析师，专注于杠杆融资和赞助商领导的交易。Makhzoumi先生目前是AETION，Inc.，American Pathology Partners，Inc.，Collective Health，Inc.，Comprehensive Pharmacy Services，Inc.，Nuvolo，Paladina Health LLC，Radiology Partners，Inc.的董事会成员。，Strive Health，LLC和WellTok，Inc.
Mohamad Makhzoumi has served as a director since March 2016. Mr. Makhzoumi is a General Partner and Head of Global Healthcare at New Enterprise Associates, where he has served in various positions since 2005. Prior to joining New Enterprise Associates, Mr. Makhzoumi served as an associate at Summit Partners, L.P. and as an analyst at UBS Group AG, concentrating on leveraged finance and sponsor-led transactions. Mr. Makhzoumi currently serves on the board of directors at Aetion, Inc., American Pathology Partners, Inc., Collective Health, Inc., Comprehensive Pharmacy Services, Inc., Nuvolo, Paladina Health LLC, Radiology Partners, Inc., Strive Health, LLC, and Welltok, Inc. - Mohamad Makhzoumi自2016年3月起担任董事。他是New Enterprise Associates公司的普通合伙人兼全球医疗保健主管，在那里他曾担任多种职务（2005年以来）。在加入New Enterprise Associates之前，Makhzoumi先生担任Summit Partners，L.P.的合伙人和瑞银集团股份公司的分析师，专注于杠杆融资和赞助商领导的交易。Makhzoumi先生目前是AETION，Inc.，American Pathology Partners，Inc.，Collective Health，Inc.，Comprehensive Pharmacy Services，Inc.，Nuvolo，Paladina Health LLC，Radiology Partners，Inc.的董事会成员。，Strive Health，LLC和WellTok，Inc.
- Mohamad Makhzoumi has served as a director since March 2016. Mr. Makhzoumi is a General Partner and Head of Global Healthcare at New Enterprise Associates, where he has served in various positions since 2005. Prior to joining New Enterprise Associates, Mr. Makhzoumi served as an associate at Summit Partners, L.P. and as an analyst at UBS Group AG, concentrating on leveraged finance and sponsor-led transactions. Mr. Makhzoumi currently serves on the board of directors at Aetion, Inc., American Pathology Partners, Inc., Collective Health, Inc., Comprehensive Pharmacy Services, Inc., Nuvolo, Paladina Health LLC, Radiology Partners, Inc., Strive Health, LLC, and Welltok, Inc.
- Adair Newhall
-
Adair Newhall自2017年5月起担任董事。Newhall先生是Greenspring Associates的合伙人，自2015年1月起担任多个职位。在加入Greenspring Associates之前，Newhall先生于2009年8月至2014年12月担任Domain Associates，LLC的负责人。加入Domain Associates，LLC之前，他曾任职Esprit Pharma，Inc.的业务开发集团，在那里他曾协助多个产品收购，以及随后将公司出售给Allergan plc。加入Domain Associates，LLC之前，Newhall先生在ESP Pharma，Inc.工作，该公司被PDLBioPharma，Inc.收购。Newhall先生目前是Crown Laboratories，Inc.的董事会成员，并且是Aetion，Inc.和Paladina Health LLC的董事会观察员。
Adair Newhall has served as a director since May 2017. Mr. Newhall is a Partner at Greenspring Associates, where he has served in various position since January 2015. Prior to Greenspring Associates, Mr. Newhall served as a principal at Domain Associates, LLC from August 2009 until December 2014. Prior to joining Domain Associates, LLC, Mr. Newhall worked in the business development group at Esprit Pharma, Inc., where he assisted with multiple product acquisitions and the subsequent sale of the company to Allergan plc. Before joining Domain Associates, LLC, Mr. Newhall worked at ESP Pharma, Inc., which was acquired by PDL BioPharma, Inc. Mr. Newhall currently serves on the board of directors of Crown Laboratories, Inc. and is a board observer at Aetion, Inc. and Paladina Health LLC. - Adair Newhall自2017年5月起担任董事。Newhall先生是Greenspring Associates的合伙人，自2015年1月起担任多个职位。在加入Greenspring Associates之前，Newhall先生于2009年8月至2014年12月担任Domain Associates，LLC的负责人。加入Domain Associates，LLC之前，他曾任职Esprit Pharma，Inc.的业务开发集团，在那里他曾协助多个产品收购，以及随后将公司出售给Allergan plc。加入Domain Associates，LLC之前，Newhall先生在ESP Pharma，Inc.工作，该公司被PDLBioPharma，Inc.收购。Newhall先生目前是Crown Laboratories，Inc.的董事会成员，并且是Aetion，Inc.和Paladina Health LLC的董事会观察员。
- Adair Newhall has served as a director since May 2017. Mr. Newhall is a Partner at Greenspring Associates, where he has served in various position since January 2015. Prior to Greenspring Associates, Mr. Newhall served as a principal at Domain Associates, LLC from August 2009 until December 2014. Prior to joining Domain Associates, LLC, Mr. Newhall worked in the business development group at Esprit Pharma, Inc., where he assisted with multiple product acquisitions and the subsequent sale of the company to Allergan plc. Before joining Domain Associates, LLC, Mr. Newhall worked at ESP Pharma, Inc., which was acquired by PDL BioPharma, Inc. Mr. Newhall currently serves on the board of directors of Crown Laboratories, Inc. and is a board observer at Aetion, Inc. and Paladina Health LLC.
- Robert J. Sheehy
-
Robert J. Sheehy，2011年2月加入本公司，担任董事；现任Genstar Capital的运营合伙人、战略咨询委员会成员，这是旧金山的一家私募股权公司，投资于领先的中间市场公司。2007-2008，他担任UnitedHealth Group的高级副总裁。2000-2007，他担任 UnitedHealthcare的首席执行官，这是UnitedHealth Group的分部。1998年4月至2000年12月，他担任UnitedHealthcare的总裁。1998年4月之前，他在UnitedHealth Group担任多个职务。他目前担任一些私营公司的董事，其中包括：Univita Health, Inc.、Evolution1 Inc.、Valence Health、Netsmart Technologies Inc. 、Foundation Medical Partners。他还是West Side Community Health Services的董事，Breck School的理事。
Robert J. Sheehy is one of our co-founders and served as Chief Executive Officer from September 2015 until April 2020 and has served as our Executive Chairman since April 2020. From 1986 to 2008 Mr. Sheehy held various executive positions at UnitedHealth Group, Inc., including as Chief Executive Officer of UnitedHealthcare, Inc. Mr. Sheehy currently serves on the Board of Directors for Radiology Partners, Inc. and the University of Michigan Health System. Following UnitedHealth Group, Inc. Mr. Sheehy served as an Operating Partner at Genstar Capital LLC, an Executive Partner at Flare Capital Partner, and a Strategic Advisor at Cimarron Healthcare Capital. Mr. Sheehy also continues to serve as an Executive Partner at Flare Capital Partners and a Strategic Advisor to Cimarron Healthcare Capital. - Robert J. Sheehy，2011年2月加入本公司，担任董事；现任Genstar Capital的运营合伙人、战略咨询委员会成员，这是旧金山的一家私募股权公司，投资于领先的中间市场公司。2007-2008，他担任UnitedHealth Group的高级副总裁。2000-2007，他担任 UnitedHealthcare的首席执行官，这是UnitedHealth Group的分部。1998年4月至2000年12月，他担任UnitedHealthcare的总裁。1998年4月之前，他在UnitedHealth Group担任多个职务。他目前担任一些私营公司的董事，其中包括：Univita Health, Inc.、Evolution1 Inc.、Valence Health、Netsmart Technologies Inc. 、Foundation Medical Partners。他还是West Side Community Health Services的董事，Breck School的理事。
- Robert J. Sheehy is one of our co-founders and served as Chief Executive Officer from September 2015 until April 2020 and has served as our Executive Chairman since April 2020. From 1986 to 2008 Mr. Sheehy held various executive positions at UnitedHealth Group, Inc., including as Chief Executive Officer of UnitedHealthcare, Inc. Mr. Sheehy currently serves on the Board of Directors for Radiology Partners, Inc. and the University of Michigan Health System. Following UnitedHealth Group, Inc. Mr. Sheehy served as an Operating Partner at Genstar Capital LLC, an Executive Partner at Flare Capital Partner, and a Strategic Advisor at Cimarron Healthcare Capital. Mr. Sheehy also continues to serve as an Executive Partner at Flare Capital Partners and a Strategic Advisor to Cimarron Healthcare Capital.
- Manuel Kadre
-
Manuel Kadre，2007年5月被选为共和废品处理公司董事，2014年3月被任命为首席独立董事。从2009年7月开始担任加勒比海黄金海岸进口商有限公司（Gold Coast Caribbean Importers, LLC）首席执行官，从2012年12月开始担任MBB汽车有限责任公司（MBB Auto, LLC）董事长和首席执行官。从1995年到2009年7月，他担任CC1公司（CC1 Companies, Inc.）多个职务，包括总裁、副总裁、总经理和秘书长，该公司在加勒比地区市场上分销可口可乐等饮料产品。他也在迈阿密大学（the University of Miami）担任受托委员会委员，担任迈阿密大学医院（University of Miami Hospital）理事。
Manuel Kadre,is currently the Chief Executive Officer of Kollective Auto Group, a premium luxury retail automotive group, and previously was Chief Executive Officer of a number of beverage, automotive, healthcare and real estate companies.Mr. Kadre has gained significant management and leadership experience from serving as Chief Executive Officer of these companies for over two decades. These experiences enable him to provide guidance regarding Republic's M&A opportunities, which is important given the role M&A plays in Republic's strategy and Republic's position in an industry where consolidation presents an opportunity to drive growth and build scale.Mr. Kadre has extensive experience strategically positioning well-known, customer-facing brands to drive customer awareness and loyalty. His focus on Republic Services, Inc. ing marketing efforts to heighten brand recognition, particularly for businesses in highly regulated industries, augments the Board's ability to oversee and provide input on marketing and sales topics.Through Mr. Kadre's leadership roles at companies in highly regulated industries, including serving as General Counsel of beverage product distributor CC1 Companies, he offers the Board valuable expertise when assessing legal and regulatory matters. In addition, he has extensive public company experience having served on four public company boards; Republic, Bright Health, The Home Depot, and Mednax. - Manuel Kadre，2007年5月被选为共和废品处理公司董事，2014年3月被任命为首席独立董事。从2009年7月开始担任加勒比海黄金海岸进口商有限公司（Gold Coast Caribbean Importers, LLC）首席执行官，从2012年12月开始担任MBB汽车有限责任公司（MBB Auto, LLC）董事长和首席执行官。从1995年到2009年7月，他担任CC1公司（CC1 Companies, Inc.）多个职务，包括总裁、副总裁、总经理和秘书长，该公司在加勒比地区市场上分销可口可乐等饮料产品。他也在迈阿密大学（the University of Miami）担任受托委员会委员，担任迈阿密大学医院（University of Miami Hospital）理事。
- Manuel Kadre,is currently the Chief Executive Officer of Kollective Auto Group, a premium luxury retail automotive group, and previously was Chief Executive Officer of a number of beverage, automotive, healthcare and real estate companies.Mr. Kadre has gained significant management and leadership experience from serving as Chief Executive Officer of these companies for over two decades. These experiences enable him to provide guidance regarding Republic's M&A opportunities, which is important given the role M&A plays in Republic's strategy and Republic's position in an industry where consolidation presents an opportunity to drive growth and build scale.Mr. Kadre has extensive experience strategically positioning well-known, customer-facing brands to drive customer awareness and loyalty. His focus on Republic Services, Inc. ing marketing efforts to heighten brand recognition, particularly for businesses in highly regulated industries, augments the Board's ability to oversee and provide input on marketing and sales topics.Through Mr. Kadre's leadership roles at companies in highly regulated industries, including serving as General Counsel of beverage product distributor CC1 Companies, he offers the Board valuable expertise when assessing legal and regulatory matters. In addition, he has extensive public company experience having served on four public company boards; Republic, Bright Health, The Home Depot, and Mednax.
- Stephen Kraus
-
Stephen Kraus，2011年7月起担任Bright Health Group, Inc.董事。2010年11月起，他担任Allena制药有限公司董事会成员。2004年起，他担任风险投资公司Bessemer Venture Partners的投资专家；2010年起担任合伙人。他是许多私人生命科学公司的董事会成员。2005至2007年，他曾担任Sirtris Pharmaceuticals, Inc. 的董事会成员；2005至2008年，担任Restore Medical, Inc. 的董事会成员。他在哈佛商学院（Harvard Business School）获得工商管理硕士学位，在耶鲁大学（Yale University）获得学士学位。
Stephen Kraus has served as a member of our board of directors since September 2011. Mr. Kraus has served as an investment professional at Bessemer Venture Partners, or BVP, a venture capital firm, since 2004 and has been a partner since 2011. He served on the board of directors of FlexPharma, Inc. NASDAQ: FLKS from April 2014 to January 2015 of Ovascience, Inc. (NASDAQ: OVAS) from July 2011 to December 2014 and of a number of privately-held life sciences companies. He previously served as a member of the board of directors of Verastem, Inc. (NASDAQ: VSTM) from November 2010 to November 2012 Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT) from 2005 to 2007 and Restore Medical, Inc. (NASDAQ: REST) from 2005 to 2008. He holds an M.B.A. from Harvard Business School and a B.A. from Yale University. - Stephen Kraus，2011年7月起担任Bright Health Group, Inc.董事。2010年11月起，他担任Allena制药有限公司董事会成员。2004年起，他担任风险投资公司Bessemer Venture Partners的投资专家；2010年起担任合伙人。他是许多私人生命科学公司的董事会成员。2005至2007年，他曾担任Sirtris Pharmaceuticals, Inc. 的董事会成员；2005至2008年，担任Restore Medical, Inc. 的董事会成员。他在哈佛商学院（Harvard Business School）获得工商管理硕士学位，在耶鲁大学（Yale University）获得学士学位。
- Stephen Kraus has served as a member of our board of directors since September 2011. Mr. Kraus has served as an investment professional at Bessemer Venture Partners, or BVP, a venture capital firm, since 2004 and has been a partner since 2011. He served on the board of directors of FlexPharma, Inc. NASDAQ: FLKS from April 2014 to January 2015 of Ovascience, Inc. (NASDAQ: OVAS) from July 2011 to December 2014 and of a number of privately-held life sciences companies. He previously served as a member of the board of directors of Verastem, Inc. (NASDAQ: VSTM) from November 2010 to November 2012 Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT) from 2005 to 2007 and Restore Medical, Inc. (NASDAQ: REST) from 2005 to 2008. He holds an M.B.A. from Harvard Business School and a B.A. from Yale University.
- G. Mike Mikan
-
G. Mike Mikan，自2013年3月他一直担任本公司董事。他自2013年1月担任ESL投资公司的总裁。他2012年4月至2012年9月担任百思买公司临时行政总裁，自1998年11月至2012年2月在UnitedHealth集团股份有限公司担任各种行政职务，包括2006年11月至2011年1月担任UnitedHealth的执行副总裁兼财务总监；从2011年6月至2012年2月，他曾担任执行副总裁及担任Optum子公司过渡性首席执行官，它是提供多元化的医疗服务公司。他2011年1月被指派到这个职位上来。他从2008年4月至2012年12月曾担任百思买的董事。
G. Mike Mikan has served as our Chief Executive Officer and President since April 2020. Mr. Mikan joined as our Vice Chairman and President in January 2019. Prior to joining Bright Health, Mr. Mikan served as Chairman and Chief Executive Officer of Shot-Rock Capital, LLC, a private investment firm, from January 2015 until December 2018. From January 2013 until December 2014 he served as President of ESL Investments, Inc. Mr. Mikan served as the Interim Chief Executive Officer of Best Buy Co., Inc. from April 2012 until September 2012. From November 1998 through February 2012 he served in various executive positions at UnitedHealth Group, Inc., including as Chief Financial Officer and as Chief Executive Officer of UnitedHealth Group’s Optum subsidiary. Mr. Mikan serves as a director of AutoNation, Inc. and Princeton Private Investments Access Fund, and as a Trustee of Ellington Income Opportunities Fund. - G. Mike Mikan，自2013年3月他一直担任本公司董事。他自2013年1月担任ESL投资公司的总裁。他2012年4月至2012年9月担任百思买公司临时行政总裁，自1998年11月至2012年2月在UnitedHealth集团股份有限公司担任各种行政职务，包括2006年11月至2011年1月担任UnitedHealth的执行副总裁兼财务总监；从2011年6月至2012年2月，他曾担任执行副总裁及担任Optum子公司过渡性首席执行官，它是提供多元化的医疗服务公司。他2011年1月被指派到这个职位上来。他从2008年4月至2012年12月曾担任百思买的董事。
- G. Mike Mikan has served as our Chief Executive Officer and President since April 2020. Mr. Mikan joined as our Vice Chairman and President in January 2019. Prior to joining Bright Health, Mr. Mikan served as Chairman and Chief Executive Officer of Shot-Rock Capital, LLC, a private investment firm, from January 2015 until December 2018. From January 2013 until December 2014 he served as President of ESL Investments, Inc. Mr. Mikan served as the Interim Chief Executive Officer of Best Buy Co., Inc. from April 2012 until September 2012. From November 1998 through February 2012 he served in various executive positions at UnitedHealth Group, Inc., including as Chief Financial Officer and as Chief Executive Officer of UnitedHealth Group’s Optum subsidiary. Mr. Mikan serves as a director of AutoNation, Inc. and Princeton Private Investments Access Fund, and as a Trustee of Ellington Income Opportunities Fund.
高管简历
中英对照 | 中文 | 英文- Sam K. Srivastava
Sam K. Srivastava，曾担任Cigna Health公司的国家和高级部门总裁。加入Cigna公司之前，他曾担任UnitedHealth Group、HealthNet的执行领导职务。他目前任职于耶鲁大学公共卫生学院（the Yale School of Public Health）、Oliver Wyman的咨询委员会。
Sam K. Srivastava serves as our Chief Executive Officer of NeueHealth as of March 2021 previously serving as our enterprise Chief Operating Officer since September 2019. Prior to joining Bright Health, Mr. Srivastava served as Chief Executive Officer of Magellan HealthCare from September 2013 to December 2018. From October 2007 to September 2013 Mr. Srivastava served as Cigna Healthcare’s President of National and Senior Segments, and led strategy and business development for the United States. Prior to Cigna, he held various executive positions at UnitedHealth Group, Inc. and Health Net, Inc. from January 1995 to September 2005 and October 2005 to October 2007 respectively, and served as a management consultant developing risk-based delivery systems for providers, insurers and governments in the U.S. and Europe. Mr. Srivastava is the Chairman of the Yale School of Public Health Advisory Board and a director for the Recovery Centers of America.- Sam K. Srivastava，曾担任Cigna Health公司的国家和高级部门总裁。加入Cigna公司之前，他曾担任UnitedHealth Group、HealthNet的执行领导职务。他目前任职于耶鲁大学公共卫生学院（the Yale School of Public Health）、Oliver Wyman的咨询委员会。
- Sam K. Srivastava serves as our Chief Executive Officer of NeueHealth as of March 2021 previously serving as our enterprise Chief Operating Officer since September 2019. Prior to joining Bright Health, Mr. Srivastava served as Chief Executive Officer of Magellan HealthCare from September 2013 to December 2018. From October 2007 to September 2013 Mr. Srivastava served as Cigna Healthcare’s President of National and Senior Segments, and led strategy and business development for the United States. Prior to Cigna, he held various executive positions at UnitedHealth Group, Inc. and Health Net, Inc. from January 1995 to September 2005 and October 2005 to October 2007 respectively, and served as a management consultant developing risk-based delivery systems for providers, insurers and governments in the U.S. and Europe. Mr. Srivastava is the Chairman of the Yale School of Public Health Advisory Board and a director for the Recovery Centers of America.
- Catherine R. Smith
Catherine R. Smith自2019年4月起担任PPG董事。她一直担任Bright Health Inc.的首席财务和行政官，该公司是一家以消费者为中心的多元化医疗保健公司，为消费者和护理提供者提供广泛的福利和服务。自2020年1月起，史密斯女士进入了美国各地市场。在加入Bright Health之前，史密斯女士曾是Target Corporation的执行副总裁兼首席财务官，Target Corporation是一家以客户为中心的全渠道零售商，在美国拥有约1850家商店，从2015年9月至2019年11月。史密斯女士曾担任Express Scripts Holding Company的执行副总裁兼首席财务官，该公司是《财富》 20强公司和美国最大的药房福利经理，于2015年3月离职。在使用Express Scripts之前，Smith女士在沃尔玛国际公司，GameStop Corp.，Centex Corp.等公司担任首席财务官一职。史密斯女士是百特国际公司的董事。
Catherine R. Smith,has been a Director of PPG since 2019. She has been Chief Financial and Administrative Officer of Bright Health Group, Inc., a diversified, consumer-focused healthcare company providing a broad range of benefits and services to consumers and care providers in local markets throughout the United States, since January 2020. Prior to joining Bright Health, Ms. Smith was Executive Vice President and Chief Financial Officer of Target Corporation, a customer-centric, omnichannel retailer with approximately 2,000 stores in the United States, from September 2015 to November 2019. From February to December 2014, Ms. Smith was Executive Vice President and Chief Financial Officer of Express Scripts Holding Company, a Fortune 20 company and the United States' largest pharmacy benefit manager, leaving the company in March 2015. Prior to Express Scripts, Ms. Smith held Chief Financial Officer positions at Walmart International, GameStop Corp., Centex Corp. and others. Ms. Smith is also a director of Baxter International Inc.- Catherine R. Smith自2019年4月起担任PPG董事。她一直担任Bright Health Inc.的首席财务和行政官，该公司是一家以消费者为中心的多元化医疗保健公司，为消费者和护理提供者提供广泛的福利和服务。自2020年1月起，史密斯女士进入了美国各地市场。在加入Bright Health之前，史密斯女士曾是Target Corporation的执行副总裁兼首席财务官，Target Corporation是一家以客户为中心的全渠道零售商，在美国拥有约1850家商店，从2015年9月至2019年11月。史密斯女士曾担任Express Scripts Holding Company的执行副总裁兼首席财务官，该公司是《财富》 20强公司和美国最大的药房福利经理，于2015年3月离职。在使用Express Scripts之前，Smith女士在沃尔玛国际公司，GameStop Corp.，Centex Corp.等公司担任首席财务官一职。史密斯女士是百特国际公司的董事。
- Catherine R. Smith,has been a Director of PPG since 2019. She has been Chief Financial and Administrative Officer of Bright Health Group, Inc., a diversified, consumer-focused healthcare company providing a broad range of benefits and services to consumers and care providers in local markets throughout the United States, since January 2020. Prior to joining Bright Health, Ms. Smith was Executive Vice President and Chief Financial Officer of Target Corporation, a customer-centric, omnichannel retailer with approximately 2,000 stores in the United States, from September 2015 to November 2019. From February to December 2014, Ms. Smith was Executive Vice President and Chief Financial Officer of Express Scripts Holding Company, a Fortune 20 company and the United States' largest pharmacy benefit manager, leaving the company in March 2015. Prior to Express Scripts, Ms. Smith held Chief Financial Officer positions at Walmart International, GameStop Corp., Centex Corp. and others. Ms. Smith is also a director of Baxter International Inc.
- Tomas Valdivia
Tomas Valdivia是我们的联合创始人之一，自2015年9月以来一直担任我们的首席健康和股权官。Valdivia博士于2012年3月至2015年3月共同创立并担任Valquist，LLC的首席执行官。Valdivia博士于2012年3月至2015年2月共同创立Luminat LLC并担任首席执行官。在加入Luminat LLC之前，Valdivia博士于2007年1月至2012年3月共同创立并担任Carol Corporation的总裁。此外，Valdivia博士曾于2000年3月至2006年5月担任Definity Health Corporation的首席健康消费者官。Valdivia博士是Intermountain Homecare和Hospice的董事会主席，Intandem Capital Partners LLC的高级顾问，并在Cliniciannexus Inc.的董事会任职。
Tomas Valdivia is one of our co-founders and has served as our Chief Health and Equity Officer since September 2015. Dr. Valdivia co-founded and served as the Chief Executive Officer of Valquist, LLC from March 2012 until March 2015. Dr. Valdivia co-founded and served as Chief Executive Officer of Luminat LLC from March 2012 until February 2015. Prior to Luminat LLC, Dr. Valdivia co-founded and served as the President of Carol Corporation from January 2007 until March 2012. In addition, Dr. Valdivia previously served as the Chief Health Consumer Officer of Definity Health Corporation from March 2000 until May 2006. Dr. Valdivia is Chairman of the Board of Trustees of Intermountain Homecare and Hospice, is senior advisor to InTandem Capital Partners LLC and serves on the board of ClinicianNexus Inc.- Tomas Valdivia是我们的联合创始人之一，自2015年9月以来一直担任我们的首席健康和股权官。Valdivia博士于2012年3月至2015年3月共同创立并担任Valquist，LLC的首席执行官。Valdivia博士于2012年3月至2015年2月共同创立Luminat LLC并担任首席执行官。在加入Luminat LLC之前，Valdivia博士于2007年1月至2012年3月共同创立并担任Carol Corporation的总裁。此外，Valdivia博士曾于2000年3月至2006年5月担任Definity Health Corporation的首席健康消费者官。Valdivia博士是Intermountain Homecare和Hospice的董事会主席，Intandem Capital Partners LLC的高级顾问，并在Cliniciannexus Inc.的董事会任职。
- Tomas Valdivia is one of our co-founders and has served as our Chief Health and Equity Officer since September 2015. Dr. Valdivia co-founded and served as the Chief Executive Officer of Valquist, LLC from March 2012 until March 2015. Dr. Valdivia co-founded and served as Chief Executive Officer of Luminat LLC from March 2012 until February 2015. Prior to Luminat LLC, Dr. Valdivia co-founded and served as the President of Carol Corporation from January 2007 until March 2012. In addition, Dr. Valdivia previously served as the Chief Health Consumer Officer of Definity Health Corporation from March 2000 until May 2006. Dr. Valdivia is Chairman of the Board of Trustees of Intermountain Homecare and Hospice, is senior advisor to InTandem Capital Partners LLC and serves on the board of ClinicianNexus Inc.
- Keith Nelsen
Keith Nelsen自2020年5月起担任我们的总法律顾问兼公司秘书。Nelsen先生担任百思买公司（BestBuy Co.）的执行副总裁兼总法律顾问。Inc.从2011年5月到2019年5月。内尔森先生还曾担任百思买公司国际部高级副总裁兼总法律顾问。从2006年9月到2011年5月，他负责监督公司与股票相关的投资。在加入百思买公司之前Nelsen从1997年9月到2006年9月担任Danka Office Imaging Co.首席行政官and General Counsel。
Keith Nelsen has served as our General Counsel and Corporate Secretary since May 2020. Mr. Nelsen served as Executive Vice President, General Counsel at Best Buy Co. Inc. from May 2011 until May 2019. Mr. Nelsen also served as SVP General Counsel, International at Best Buy Co. Inc. from September 2006 until May 2011 where he oversaw the company’s equity-related investments. Prior to joining Best Buy Co. Inc., Mr. Nelsen served as Chief Administrative Officer and General Counsel of Danka Office Imaging Co. from September 1997 until September 2006.- Keith Nelsen自2020年5月起担任我们的总法律顾问兼公司秘书。Nelsen先生担任百思买公司（BestBuy Co.）的执行副总裁兼总法律顾问。Inc.从2011年5月到2019年5月。内尔森先生还曾担任百思买公司国际部高级副总裁兼总法律顾问。从2006年9月到2011年5月，他负责监督公司与股票相关的投资。在加入百思买公司之前Nelsen从1997年9月到2006年9月担任Danka Office Imaging Co.首席行政官and General Counsel。
- Keith Nelsen has served as our General Counsel and Corporate Secretary since May 2020. Mr. Nelsen served as Executive Vice President, General Counsel at Best Buy Co. Inc. from May 2011 until May 2019. Mr. Nelsen also served as SVP General Counsel, International at Best Buy Co. Inc. from September 2006 until May 2011 where he oversaw the company’s equity-related investments. Prior to joining Best Buy Co. Inc., Mr. Nelsen served as Chief Administrative Officer and General Counsel of Danka Office Imaging Co. from September 1997 until September 2006.
- Simeon Schindelman
Simeon Schindelman自2019年9月起担任Bright医疗保健首席执行官。在加入Bright Health之前，Schindelman先生于2016年2月至2020年10月担任Create Health Plans的创始人兼首席执行官，并于2015年12月至2019年4月担任Brighton Health Plan Solutions，LLC的首席执行官。加入Create Health Plans和Brighton Health Plan Solutions之前，Schindelman从2012年11月到2015年9月担任Bloom Health，Inc.（设计，建造和运营私人交易所的领导者）董事长兼首席执行官。在Bloom Health，Inc.之前，Schindelman先生在医疗保健公司担任多个管理职位，包括Medica Health Plans Inc.和UnitedHealth Group，Inc.。Schindelman先生目前担任JLL Partners，LLC，Eden Health，Inc.和IBM Corporation’；s Watson Health Division的顾问。
Simeon Schindelman has served as Chief Executive Officer of Bright HealthCare since September 2019. Prior to joining Bright Health, Mr. Schindelman served as founder and Chief Executive Officer of Create Health Plans from February 2016 to October 2020 and Chief Executive Officer of Brighton Health Plan Solutions, LLC from December 2015 to April 2019. Prior to joining Create Health Plans and Brighton Health Plan Solutions, Mr. Schindelman served as the Chairman and Chief Executive Officer of Bloom Health, Inc. a leader in designing, building and operating private exchanges, from November 2012 to September 2015. Prior to Bloom Health, Inc., Mr. Schindelman held various managements position in healthcare companies, including Medica Health Plans Inc. and UnitedHealth Group, Inc. Mr. Schindelman currently serves as an advisor to JLL Partners, LLC, Eden Health, Inc. and IBM Corporation’s Watson Health division.- Simeon Schindelman自2019年9月起担任Bright医疗保健首席执行官。在加入Bright Health之前，Schindelman先生于2016年2月至2020年10月担任Create Health Plans的创始人兼首席执行官，并于2015年12月至2019年4月担任Brighton Health Plan Solutions，LLC的首席执行官。加入Create Health Plans和Brighton Health Plan Solutions之前，Schindelman从2012年11月到2015年9月担任Bloom Health，Inc.（设计，建造和运营私人交易所的领导者）董事长兼首席执行官。在Bloom Health，Inc.之前，Schindelman先生在医疗保健公司担任多个管理职位，包括Medica Health Plans Inc.和UnitedHealth Group，Inc.。Schindelman先生目前担任JLL Partners，LLC，Eden Health，Inc.和IBM Corporation’；s Watson Health Division的顾问。
- Simeon Schindelman has served as Chief Executive Officer of Bright HealthCare since September 2019. Prior to joining Bright Health, Mr. Schindelman served as founder and Chief Executive Officer of Create Health Plans from February 2016 to October 2020 and Chief Executive Officer of Brighton Health Plan Solutions, LLC from December 2015 to April 2019. Prior to joining Create Health Plans and Brighton Health Plan Solutions, Mr. Schindelman served as the Chairman and Chief Executive Officer of Bloom Health, Inc. a leader in designing, building and operating private exchanges, from November 2012 to September 2015. Prior to Bloom Health, Inc., Mr. Schindelman held various managements position in healthcare companies, including Medica Health Plans Inc. and UnitedHealth Group, Inc. Mr. Schindelman currently serves as an advisor to JLL Partners, LLC, Eden Health, Inc. and IBM Corporation’s Watson Health division.
- G. Mike Mikan
G. Mike Mikan，自2013年3月他一直担任本公司董事。他自2013年1月担任ESL投资公司的总裁。他2012年4月至2012年9月担任百思买公司临时行政总裁，自1998年11月至2012年2月在UnitedHealth集团股份有限公司担任各种行政职务，包括2006年11月至2011年1月担任UnitedHealth的执行副总裁兼财务总监；从2011年6月至2012年2月，他曾担任执行副总裁及担任Optum子公司过渡性首席执行官，它是提供多元化的医疗服务公司。他2011年1月被指派到这个职位上来。他从2008年4月至2012年12月曾担任百思买的董事。
G. Mike Mikan has served as our Chief Executive Officer and President since April 2020. Mr. Mikan joined as our Vice Chairman and President in January 2019. Prior to joining Bright Health, Mr. Mikan served as Chairman and Chief Executive Officer of Shot-Rock Capital, LLC, a private investment firm, from January 2015 until December 2018. From January 2013 until December 2014 he served as President of ESL Investments, Inc. Mr. Mikan served as the Interim Chief Executive Officer of Best Buy Co., Inc. from April 2012 until September 2012. From November 1998 through February 2012 he served in various executive positions at UnitedHealth Group, Inc., including as Chief Financial Officer and as Chief Executive Officer of UnitedHealth Group’s Optum subsidiary. Mr. Mikan serves as a director of AutoNation, Inc. and Princeton Private Investments Access Fund, and as a Trustee of Ellington Income Opportunities Fund.- G. Mike Mikan，自2013年3月他一直担任本公司董事。他自2013年1月担任ESL投资公司的总裁。他2012年4月至2012年9月担任百思买公司临时行政总裁，自1998年11月至2012年2月在UnitedHealth集团股份有限公司担任各种行政职务，包括2006年11月至2011年1月担任UnitedHealth的执行副总裁兼财务总监；从2011年6月至2012年2月，他曾担任执行副总裁及担任Optum子公司过渡性首席执行官，它是提供多元化的医疗服务公司。他2011年1月被指派到这个职位上来。他从2008年4月至2012年12月曾担任百思买的董事。
- G. Mike Mikan has served as our Chief Executive Officer and President since April 2020. Mr. Mikan joined as our Vice Chairman and President in January 2019. Prior to joining Bright Health, Mr. Mikan served as Chairman and Chief Executive Officer of Shot-Rock Capital, LLC, a private investment firm, from January 2015 until December 2018. From January 2013 until December 2014 he served as President of ESL Investments, Inc. Mr. Mikan served as the Interim Chief Executive Officer of Best Buy Co., Inc. from April 2012 until September 2012. From November 1998 through February 2012 he served in various executive positions at UnitedHealth Group, Inc., including as Chief Financial Officer and as Chief Executive Officer of UnitedHealth Group’s Optum subsidiary. Mr. Mikan serves as a director of AutoNation, Inc. and Princeton Private Investments Access Fund, and as a Trustee of Ellington Income Opportunities Fund.